178 related articles for article (PubMed ID: 27743982)
1. Spontaneous tumour lysis syndrome in hepatocellular carcinoma presenting with hypocalcemic tetany: An unusual case and systematic literature review.
Agarwala R; Batta A; Suryadevera V; Kumar V; Sharma V; Rana SS
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):e29-e31. PubMed ID: 27743982
[TBL] [Abstract][Full Text] [Related]
2. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.
Kanayama M; Nagai H; Sumino Y
Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100
[TBL] [Abstract][Full Text] [Related]
3. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma.
Imam SZ; Zahid MF; Maqbool MA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):168-170. PubMed ID: 29684339
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
Wen J; Shen WL; Yang SH
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report.
Shiozawa K; Watanabe M; Takenaka H; Nagai H; Ishii K; Sakai K; Sumino Y
Hepatogastroenterology; 2010; 57(101):688-90. PubMed ID: 21033210
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients.
Gomatos IP; Alexakis N; Koskinas J; Smparounis SA; Katsaragakis S; Konstadoulakis MM; Zografos GC
Am Surg; 2013 Jan; 79(1):111-3. PubMed ID: 23317624
[No Abstract] [Full Text] [Related]
9. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
10. [Liver resection after downstaging with systemic chemotherapy in a case of a multicentric hepatocellular carcinoma with virus B cirrhosis].
Ionescu M; Dumitraşcu T; Stroescu C
Chirurgia (Bucur); 2007; 102(3):337-43. PubMed ID: 17687865
[TBL] [Abstract][Full Text] [Related]
11. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient.
Kim JO; Jun DW; Tae HJ; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC; Hahm JS
Clin Mol Hepatol; 2015 Mar; 21(1):85-8. PubMed ID: 25834806
[TBL] [Abstract][Full Text] [Related]
12. Acute tumor lysis syndrome after transarterial chemoembolization for well-differentiated hepatocellular carcinoma with neuroendocrine features.
Wang K; Chen Z
Onkologie; 2010; 33(10):532-5. PubMed ID: 20926901
[TBL] [Abstract][Full Text] [Related]
13. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.
Drakos P; Bar-Ziv J; Catane R
Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169
[TBL] [Abstract][Full Text] [Related]
14. Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma.
Katiman D; Manikam J; Goh KL; Abdullah BJ; Mahadeva S
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S187-90. PubMed ID: 22692948
[No Abstract] [Full Text] [Related]
15. Tumor Lysis Syndrome: A Serious Complication of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Jiang RD; Jian WC; Jin N; Zhang ZL; Li T
Am J Med; 2016 Sep; 129(9):e173-6. PubMed ID: 27155110
[No Abstract] [Full Text] [Related]
16. Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report.
Chao CT; Chiang CK
Med Princ Pract; 2012; 21(5):498-500. PubMed ID: 22687814
[TBL] [Abstract][Full Text] [Related]
17. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
18. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.
Camarata M; Davies R; Copley S; Blagden S
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon.
Dhakal P; Rai MP; Thrasher M; Sharma M
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29898908
[TBL] [Abstract][Full Text] [Related]
20. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation.
Kita Y; Klintmalm G; Kobayashi S; Yanaga K
Dig Dis Sci; 2007 Dec; 52(12):3392-3. PubMed ID: 17404871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
